Literature DB >> 4029946

Creatine kinase subunits M and B as markers in the diagnosis of poorly differentiated rhabdomyosarcomas in children.

A S de Jong, M van Kessel-van Vark, C E Albus-Lutter, P A Voûte.   

Abstract

Antibodies against the M and B subunits of creatine kinase were assessed for their usefulness in the diagnosis of poorly differentiated rhabdomyosarcoma. Routinely processed formaldehyde-fixed tissue and the avidin-biotin-peroxidase complex technique were used. The majority of the poorly differentiated and all of the moderately and well-differentiated rhabdomyosarcomas studied showed immunostaining for the M subunit. The rhabdomyoblastic component of malignant "triton" tumors was also positive. Staining, although weak compared with that of the rhabdomyosarcomas, was also observed in a few leiomyosarcomas, hemangioendotheliosarcomas, malignant fibrous histiocytomas, and ganglioneuroblastomas. On the other hand, staining for the B subunit was seen in many types of soft tissue tumors, including rhabdomyosarcoma, Ewing's sarcoma, and (ganglio)neuroblastoma. The results indicate that creatine kinase subunit M is a useful marker for distinguishing poorly differentiated rhabdomyosarcoma from other types of small round cell tumors in children, such as neuroblastoma, Ewing's sarcoma, and malignant lymphoma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4029946     DOI: 10.1016/s0046-8177(85)80131-3

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  4 in total

1.  Diagnosis of rhabdomyosarcomas with HHF35, a monoclonal antibody directed against muscle actins.

Authors:  R A Schmidt; R Cone; J E Haas; A M Gown
Journal:  Am J Pathol       Date:  1988-04       Impact factor: 4.307

2.  HHF35, a muscle actin-specific monoclonal antibody. II. Reactivity in normal, reactive, and neoplastic human tissues.

Authors:  T Tsukada; M A McNutt; R Ross; A M Gown
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

3.  Evaluation of desmin as a diagnostic and prognostic marker of childhood rhabdomyosarcomas and embryonal sarcomas.

Authors:  P Dias; P Kumar; H B Marsden; P H Morris-Jones; J Birch; R Swindell; S Kumar
Journal:  Br J Cancer       Date:  1987-09       Impact factor: 7.640

4.  Characterization of a new human embryonal rhabdomyosarcoma cell line, RMS-GR.

Authors:  J E Fernández; J Prados; C Melquizo; N Arena; F Malavasi; L Alvarez; A Aránega
Journal:  Jpn J Cancer Res       Date:  1998-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.